CTDSP2 and glioblastoma: Among the cohorts with sufficient sample sizes for RNA-seq analysis, we find that an enhancer of CTDSP2 is a putative driver in brain cancer (glioblastoma multiforme), and the SVs are associated with its differential expression (Fig. 6f).